Rare diseases
Investigational molecules
Locations
Back to Italy142 clinical trials in Alexandria, Italy across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of Mosunetuzumab and Zanubrutinib for Patients with Relapsed or Refractory Follicular Lymphoma
ItalyStudy of Galinpepimut-S compared to standard therapy for patients with acute myeloid leukemia who achieved complete remission after second-line treatment
ItalyStudy on the Safety and Effectiveness of Venetoclax, Atezolizumab, and Obinutuzumab for Patients with Richter Syndrome from Chronic Lymphocytic Leukemia
ItalyStudy on the Safety and Effectiveness of Fianlimab, Cemiplimab, and Chemotherapy in Adults with Resectable Non-Small Cell Lung Cancer
ItalyStudy on De-escalated Induction Therapy with Methotrexate, Cytarabine, Thiotepa, and Rituximab for Newly Diagnosed Primary CNS Lymphoma Patients
ItalyStudy of Atezolizumab and Drug Combination for Patients with Relapsed or Refractory Hodgkin's Lymphoma Eligible for Stem Cell Transplant
ItalyStudy of Navtemadlin for Patients with Myelofibrosis Resistant to JAK Inhibitors
ItalyStudy on Prednisone and Vitamin D for Elderly Patients with Diffuse Large B-Cell Lymphoma
ItalyItalyStudy of Epcoritamab for Patients with Relapsed, Progressive, or Refractory B-Cell Lymphoma
ItalyItalyStudy Comparing Radium-223 Dichloride with Abiraterone Acetate, Enzalutamide, and Prednisone in Patients with Advanced Prostate Cancer Spread to the Bone
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on blood cancers and related disorders, including studies on innovative treatments for lymphoma, leukemia, and multiple myeloma. Clinical trials are evaluating novel therapeutic combinations and targeted approaches.
Investigations include immunotherapy combinations and maintenance strategies for improved patient outcomes.
Studies focusing on preventing and treating respiratory infections and conditions, with particular emphasis on vulnerable populations. Research includes vaccine development and therapeutic interventions.
Trials are exploring novel treatments and preventive strategies for respiratory conditions.
Important studies in heart failure prevention and treatment, investigating new therapeutic combinations and strategies to reduce cardiovascular risks in high-risk populations.
Research focuses on innovative drug combinations to prevent heart failure events and improve outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
